Respiratory Syncytial Virus (RSV) Infections drugs in development, 2023

GlobalData tracks 184 drugs in development for Respiratory Syncytial Virus (RSV) Infections by 144 companies/universities/institutes. The top development phase for Respiratory Syncytial Virus (RSV) Infections is preclinical, with 92 drugs in that stage.

Europe’s lessons for the U.S. on how to cover weight loss drugs

It’s no secret that the obesity epidemic in the United States has reached alarming levels, with rates surpassing 40% of the population. Despite a robust

December 14, 2023

Access to Abortion Training Important to Ob/Gyn Residency Applicants Post-Roe

SAN FRANCISCO — Access to abortion training was an important consideration among those applying to ob/gyn residency in the match cycle after the Dobbs v.

May 22, 2024

Clot-busting drug alteplase shows promise for stroke treatment up to 24 hours after onset

The clot-dissolving medication, alteplase, improved stroke patients’ recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke,

February 9, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.